EMA shifts to Amsterdam; may lose quarter staff post relocation

By PharmaCompass

2019-01-17

Impressions: 160 Article

The European Union Medicines Agency (EMA) finally moved from London to Amsterdam last week. The EMA’s executive director Guido Rasi was presented a pair of clogs to mark its relocation.

The EMA’s new US$ 346 million (€300 million) headquarters is currently under construction. Therefore, its 900 employees will first work out of temporary offices near the city's main train station until November.

After closely monitoring its staffers’ intentions, the agency expects to lose about 25 percent of its staff. In addition to the staffing losses, EMA said it will temporarily reduce or suspend activities in the first half of 2019 as it moves into the final phase of its physical relocation.

For instance, between February 11 and March 15, 2019, no pre-submission meetings for initial marketing authorization applications will take place. EMA will also not print or dispatch certificates for pharmaceutical products from February 25 until March 14, 2019, though companies can still submit requests during this period, which EMA will continue to process.

The PharmaCompass Newsletter – Sign Up, Stay Ahead

Feedback, help us to improve. Click here

Image Credit : #Phisper Infographic by SCORR MARKETING & PharmaCompass is licensed under CC BY 2.0

“ The article is based on the information available in public and which the author believes to be true. The author is not disseminating any information, which the author believes or knows, is confidential or in conflict with the privacy of any person. The views expressed or information supplied through this article is mere opinion and observation of the author. The author does not intend to defame, insult or, cause loss or damage to anyone, in any manner, through this article.”

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass